Clinical Study of TQB2223 Injection Combined With AK105 Injection in the Treatment of Advanced Hepatocellular Carcinoma.
Clinical trial NCT06320080 · TERMINATED
Trial details
- NCT number
- NCT06320080
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-30
- Primary completion
- 2025-11-03
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.